TWiV 1008: Clinical update with Dr. Daniel Griffin
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In his weekly clinical update, Dr. Griffin discusses variant specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on omicron VOC, ventilation in buildings, COVID-19 mortality among selective serotonin reuptake inhibitor users, risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses, trajectories of the evolution of post COVID-19 condition, and efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Virus variant clinical performance of a SARS-CoV-2 rapid antigen test (CID)
- Ventilation in buildings (CDC)
- COVID-19 mortality among SSRI users (CMI)
- Risk of post-acute sequelae of SARS-CoV-2 infection associated with sleep apnea (SLEEP)
- Trajectories of the evolution of post COVID-19 condition (IJID)
- Efficacy of cognitive behavioral therapy targeting fatigue following COVID-19 (CAD)
- Contribute to our FIMRC fundraiser at PWB
- Letters read on TWiV 1008
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]